Skip NavigationSkip to Content
NCI HeaderNational Cancer InstituteU.S. National Institutes of Healthwww.cancer.gov
CCR - For Our Staff| Home |

Preparing for Private Sector Careers in Biotechnology and Pharmaceutical Industries (PPSC)

Preparing for Private Sector Careers in Biotechnology and Pharmaceuticals

In early 2014, NCI’s Center for Cancer Research (CCR) will be hosting a new and improved workshop to help fellows and staff scientists familiarize themselves with job opportunities available in biotechnology and pharmaceutical industries that are outside of traditional academia.  We had a very successful workshop last year and have expanded this year to include speakers with higher seniority and from a greater variety of backgrounds (not just scientists). 

Given that job opportunities in industry may include roles outside of traditional bench sciences, this workshop brings in resources that should help you prepare and make informed decisions about your potential future endeavors. The workshop will feature invited speakers from industry who will present important information for success at various jobs within the biotechnology and pharmaceutical industries. They will share their experiences and the individual journeys that brought them to choose and remain in industry while describing best practices for getting a job, setting work expectations and imparting how to navigate unique business-oriented scientific cultures.  We hope this workshop will help shed light on how to position yourself for a potential private sector career and improve your chances of succeeding should you choose this professional route.

The workshop will include speakers from different backgrounds. The private sector hires people with scientific backgrounds for a wide variety of functions, not all of which directly involve bench science.  Reviewing the biographies of our invited speakers should help reveal the type of job functions on which they can provide their expertise.

Some of the major takeaways from previous workshops include:

  • There are significant differences in the application and interview processes for non-academic versus academic positions.
  • It is far better to begin your job preparation earlier rather than later (preferably during your first year at NIH)
  • There are many positions that exist within industry that do not involve bench sciences and require unique processes and preparation. This requires preparation on your part so you can recognize what skills you may already possess for these types of job openings
  • This workshop helps participants identify opportunities to pursue at NIH which will better position them for the future.

The workshop will cover topics such as:

  • Jobs available for scientists at smaller niche firms to larger multi-business corporations
  • Interpreting different job postings
  • What companies look for in candidates
  • Opportunities in intellectual property protection
  • Cover letter and resume writing best practices for specific jobs and industries
  • How to leverage experiences at NCI-CCR to develop the skills to succeed in industry
  • Developing leadership, financial, behavioral and scientific skills and effectively conveying these skills to employers
  • Interview preparation best practices, negotiation tips (when, when not to and how)
  • Industry business culture
  • Transitioning from academic research to industry—new and different roles
  • Expectations for collaboration across divisions within companies
  • Metrics for success

Locations and Times

The first session will be held on Friday, January 17th (Bldg. 37/Rm. 4041, Bethesda campus). Subsequent sessions will be held every Thursday at 3:00 pm for 12 weeks on the Bethesda campus, starting January 23nd through April 10th, 2014 in Bldg. 37/Conference Rm. 6041.

For More Information

Contact Dr. Ravi Dhar, PhD, CCR Office of Training and Education, at dharr@od.nih.gov or 301-496-0990.

Schedule and Speakers

Except for the first session held Friday, January 17th, in Bldg 37/Rm. 4041, the workshop will be held at 3:00 pm every Thursday in Bldg. 37/ Rm.6041 from January 23rd, 2014 through April 10th, 2014. Click on each speaker to view their biosketch and the topics to be discussed.

Date

Speaker

Affiliation

January  17

Bettina Haedrich, PhD, MBA

Director, Corporate Business Development
QIAGEN
Germany

January 23

Kelly Lyn Warfield, PhD

Vice President, Vaccine Development
Integrated Biotherapeutics, Inc.
21 Firstfield Road, Suite 100
Gaithersburg, MD 20878
kelly@integratedbiotherapeutics.com

January 30

Rosemarie Truman            

Founder and CEO
The Center for Advancing Innovation
Tel: 202-438-2208
rtruman@thecenterforadvancinginnovation.org
www.thecenterforadvancinginnovation.org

February 6

Donna Robertson-Chow, PhD

Senior Patent Agent
Celgene Corporation
Summit, NJ

February 13, 20, 27

Randall K. Ribaudo, PhD

Co-founder, SciPhD Training Programs
President and CEO
Human Workflows, LLC
www.sciphd.com

March 6

Anita Krithivas Gandhi, PhD

Drug Development at Celgene
The IMiD Story
Careers in Translational Development

March 13 

Steven M. Ferguson, CLP

Deputy Director, Licensing & Entrepreneurship
Office of Technology Transfer, NIH
6011 Executive Boulevard, Suite 325
Rockville, MD 20852
sf8h@nih.gov
www.ott.nih.gov

 

Jeffery W. Thomas, PhD

Frederick Unit Supervisor  
Technology Transfer Center, NCI                                
jeffreyt@mail.nih.gov
http://ttc.nci.nih.gov/

March 20

Giovanni Melillo, MD 

Senior Medical Director
Global Medicines Development
AstraZeneca Oncology
Gaithersburg, MD 20878

March 27

Judy Britz, PhD

Executive Director
BioMaryland Center
jbritz@Bio.Maryland.gov
http://bio.maryland.gov/Pages/default.aspx

April 3

Douglas Doerfler

President and CEO
MaxCyte, Inc.

April 10

Anjan Thakurta, PhD

Senior Director
Translational Development, Multiple Myeloma
Celgene Corporation
86 Morris Ave, Summit, NJ
athakurta@celgene.com

 

 

Bettina Haedrich, PhD, MBA

Director Corporate Business Development
QIAGEN
Germany

Bettina Haedrich has served as the Director of Corporate Business Development at QUIGEN since 2008.  She leads the development of QIAGEN’s roadmap and acquisition pipeline as well as investment strategy in the next generation sequencing and bioinformatics market.  From 2000-2008, Bettina previously held several international management positions in sales and marketing at QIAGEN, where she oversaw the commercialization of highly innovative technologies in the genomics field. Prior to QIAGEN, Bettina spent four years in R&D at Evonik where she coordinated a strategic initiative to explore industrial applications of microbial genome analysis and the transfer of the gained knowledge to manufacturing of feed additives. Bettina also gained significant experience in marketing of products in the molecular diagnostic industry as a Product Manager for diagnostic instruments. She holds a Ph.D. from University of Düsseldorf and an Executive MBA from Kellogg, Evanston and WHU, Vallendar and is the author of several scientific publications and more than 40 patents in the field of genome analysis.

QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of September 30, 2013, QIAGEN employed more than 4,100 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

Topics Bettina will cover in her lecture include:

  • Job profiles in biotech industry in R&D and outside of traditional bench sciences
  • What to expect in development, manufacturing, marketing or business development
  • Career path examples and development opportunities
  • Working in international teams
  • A typical working day in a global biotech company
  • Takeaways from working in global biotech companies

Kelly Lyn Warfield, PhD

Vice President, Vaccine Development
Integrated Biotherapeutics, Inc.
21 Firstfield Road, Suite 100
Gaithersburg, MD 20878
kelly@integratedbiotherapeutics.com

Dr. Kelly Lyn Warfield began her scientific career as a student intern at the National Institute of Standards and Technologies and National Cancer Institute.  Following college at Loyola College in Maryland, Dr. Warfield received her Ph.D. degree in molecular virology from Baylor College of Medicine in Houston, Texas by studying immune responses and pathogenesis of rotavirus infections, as well as investigating adverse events related to rotavirus vaccination and infection, using animal models.  Further training during a National Research Council postdoctoral fellowship at the United States Army Medical Research Institute of Infectious Diseases allowed Dr. Warfield to become specially trained in BSL-3 and BSL-4 containment laboratories studying pathogenesis, developing animal models and vaccines and therapeutics for the highly lethal filoviruses.  Currently, Dr. Warfield works in the biotechnology industry at Integrated Biotherapeutics, Inc. as the Vice President of Vaccine Development and is focused on development of antivirals and vaccines for Ebola and Marburg viruses.  She is also a scientific advisor to Unither Virology regarding the preclinical development activities for a broad-spectrum antiviral for indications including uncomplicated dengue and influenza virus infections.

Topics to be covered in her lecture include:

  • Transitioning from academic research to industry
  • Differences between academia and industry
  • What can a PhD do in the industry?
  • How do you prepare yourself for a career in industry?
  • Learning project management
  • Working in a matrix and team-oriented atmosphere
  • Managing multiple projects and deadlines in a fast-paced environment
  • Delivering results and managing expectations
  • Written and verbal communication skills

Rosemarie Truman

Founder and CEO
The Center for Advancing Innovation (CAI)
Tel: 202-438-2208
rtruman@thecenterforadvancinginnovation.org

Rosemarie has over 20 years of experience in driving growth for clients, having created over $21 billion in new profits for clients that launched over 100 new products/services/solutions. Her experience spans strategy consulting, investment banking, and entrepreneurship. Rosemarie has provided strategy consulting services for over 110 clients in over 15 countries and 24 states. Having started her career at Goldman Sachs as an analyst, to this day, Rosemarie's core competencies are in complex due diligence and portfolio strategy, creating sustainable growth breakthrough strategies for clients and transformation

Currently, Ms. Truman is founder and CEO of a global public-private partnership whose mission is to accelerate and increase the volume of technology transfer, translational research and commercialization.  Her firm, The Center for Advancing Innovation, has been working with the Avon Foundation on Portfolio Strategy and also has Partnership Intermediary agreements with the National Institutes of Health, National Cancer Institute, the National Heart, Lung and Blood Institute and six other research institutes within the NIH.  Recently her team completed a portfolio analysis effort of over 4,000 NCI inventions.  With AF and NCI, her firm is serving as managing director of a first-of-a-kind national business plan and startup Challenge for select breast cancer focused inventions.

Prior to launching her own firm, Rosemarie served as the global leader of IBM and PRTM's Innovation and R&D strategy practice; the VP and head of global strategy at Marsh & McLennan; leader in Oracle's Advanced Technology Group and also led eBusiness Strategy while at Ernst & Young and Booz Allen & Hamilton.  At IBM, Rosemarie also led internal transformation efforts in the Emerging Business Opportunity area to create models that drive sustainable "growth breakthroughs." Among the numerous awards Rosemarie has earned, she has been awarded IBM's highest award, The Golden Circle Award that only 150 of 350,000 employees receive. Finally, Rosemarie has spearheaded the development of several trade secret models and frameworks to select and nurture sustainable growth opportunities; one model is for the Life Sciences industry called "Industry Leading R&D Performance."  Rosemarie has worked across industries, including Life Sciences, Technology Transfer, Oil & Gas, Consumer Packaged Goods, Automotive, Aerospace & Defense, Financial Services, and High Tech.

Topics Rosemarie will cover in her lecture include:

  • Overview of a career as a strategy consultant
  • Types of consulting firms – strategy; operations and implementation
  • Practices for getting different types of non-academic positions
  • Consulting firm work in reality
  • What consulting firms look for in your resume
  • How to get in the door

Please visit the CAI website for detail.  There are some good videos to give you a sense of what they do: www.thecenterforadvancinginnovation.org

Donna Robertson-Chow, PhD

Senior Patent Agent
Celgene Corporation
Summit, NJ

Donna Robertson is a U.S. Patent and Trademark Office (USPTO)-registered patent agent with over 17 years of experience in intellectual property law. She received her Ph.D. from Cornell University Graduate School of Medical Sciences in the field of pharmacology. Her initial training in patent law was at Kalow & Springut, LLP, a boutique patent law firm in New York City. She has been an in-house patent agent at several companies including Emisphere Technologies, Taro Pharmaceuticals, and General Electric and currently at Celgene Pharmaceuticals in Summit, New Jersey. Dr. Robertson has prepared and prosecuted applications in a variety of technologies including chemicals, airplane and train engine design, water filtration units, LED technology, bioengineering and pharmaceuticals. Her experience includes working with scientists and project teams to prepare and prosecute patent applications and participating in opposition and litigation strategy in U.S. and worldwide proceedings.

Donna will discuss the ins and outs of how you can make a career in intellectual property protection.

Randall K. Ribaudo, PhD

Co-founder, SciPhD Training Programs
President, CEO
Human Workflows, LLC
www.sciphd.com

Human Workflows and SciPhD co-founder Dr. Randall Ribaudo, a former NCI Principle Investigator, has over twenty years of experience in the Scientific Research and Biotechnology fields and has successfully made the transition from academia to industry.  Dr. Ribaudo co-founded Human Workflows after more than five years at Celera Genomics.  During his time at Celera, Dr. Ribaudo acted as liaison between Celera and the pharmaceutical, biotechnology and academic communities, served as product manager responsible for developing support products for the Proteomics Groups mass spectrometry software, led the iScience Task Force to define strategic directions for sister company Applied Biosystems, advised on product development for the Celera Discovery System and enterprise solutions for information integration and worked as a Manager of Strategic Solutions in the Informatics business.

Prior to Celera, Dr. Ribaudo worked at the biotechnology and bioinformatics company Molecular Applications Group.  Dr. Ribaudo was responsible for presenting the capabilities of MAG's products to representatives in the pharmaceutical, biotechnology and academic communities.

Dr. Ribaudo also has extensive experience in academic biological life sciences as well. After receiving a Ph.D. in Immunology at the University of Connecticut, Dr. Ribaudo joined the Laboratory of Immunology, NIAID at the National Institutes of Health where he studied the molecular basis of antigen presentation.  Dr. Ribaudo then accepted a position in the National Cancer Institute in the Laboratory of Immune Cell Biology as a Principal Investigator where he developed his own research program studying the immune response to viruses and tumors, leading a team of postdoctoral fellows, technicians, and university and high school students.  His work at the National Cancer Institute led to the development of a novel technology to develop vaccines against tumors and viruses.  Dr. Ribaudo holds patents for this technology which are now being further developed by private companies.

His experiences have provided Dr. Ribaudo with tremendous insight into the rapidly exploding technological capabilities in areas of discovery research, information and data management, as well as a detailed understanding of the skills and competencies required for scientists to be successful in industry careers.

Dr. Ribaudo will be holding workshops on three days.  Details are included below.

Workshop Descriptions

Workshop 1: The Business of Science

Adapting to industry jobs can be a significant challenge for scientists coming from academia. Industry values and requires skills that go beyond the traditional scientific/technical competencies. The ability to work in cross-matrixed environments, demonstrate solid tactical and strategic thinking, ability to delegate, communicate and understand basic concepts of project management are common prerequisites for jobs in industry.  Although these skills are not typically emphasized during academic training, many research activities do in fact map to these competencies. Having an awareness of your skills and an ability to express those skills in business terms provides a significant competitive advantage in landing an industry job and being successful in that job.

This training workshop introduces 24 business competencies valued in industry, relates them to post-doc research experiences, and demonstrates how to identify those competencies in defining your Scientific, Business and Social Identities, and how to relate them to job ads and descriptions. We will also discuss industry's perception of academic scientists with regard to their assumed strengths and weaknesses and how to leverage that knowledge along with an understanding of your own real capabilities to build your “brand” that will advance your career.

Access to the SciPhD online self-assessment is also included. This instrument profiles your own competencies in these 24 areas and maps your strengths to different job types in different types of companies. This information can be used in developing resumes, cover letters, preparing for interviews, and for short and long term career planning.

Workshop 2: Demystifying Job Ads to Develop Targeted Resumes, Build your Network and Prepare for Interviews

In the second workshop, we will look at how to demystify job ads to identify the explicit and implicit information they contain, and how to use that information in conjunction with the results of your self assessment and additional intelligence through smart networking to make you competitive for jobs you desire through developing targeted resumes and talking points for interviews. Additionally, understanding the social context of these competencies, and how they relate to each other provides foundations for not just obtaining industry jobs, but for excelling and succeeding in an industry career.

Key topics that will be discussed include:

  • 24 business competencies companies are looking for in new hires
  • Translating your research experiences into the 24 competencies
  • Solving the industry prejudice against academics "lack of experience"
  • Matching your skills to the job ad in your targeted resume
  • Five questions to ask during your interview
  • The three questions you have to be prepared to answer
  • Understanding and marketing your three identities that separate you from the competition
  • Five key action items for building your network
  • Free access to SciPhD online training course and self-assessment

Workshop 3:  Strategic Project Management for Scientists

Students will learn the three cornerstones of project management: “time”, “cost” and “objectives”, and how to manage those three critical entities using combinations of the 24 core competencies introduced in the first session.  Students will learn the importance of tactical planning, communications, negotiation, and control in being an effective project manager.  Students will become familiar with the tools and language of project management so that they can more effectively fit into cross-matrixed teams, and in some cases even assume the role of project manager.  Examples drawn from familiar scientific experiences will be used to demonstrate the various aspects of effective project management, the benefits of it being used properly, and the consequences when it is not. Upon completion you will be able to:

  1. Look at any project and immediately determine who is your customer (you can only have one!)
  2. Identify the critical objectives
  3. Develop a project plan to meet those objectives.

Testimonials about the course: http://www.sciphd.com/SciPhD.com/Testimonials.html

Anita Krithivas Gandhi, PhD

Drug Development at Celgene
The IMiD Story
Careers in Translational Development

Dr. Gandhi is a Senior Principal Scientist in Translational Development at Celgene Corporation. Dr. Gandhi received a BS degree in Biology from Tufts University (1996), and following one year as a lab technician at the Dana Farber Cancer Institute, a PhD degree in 2002 from the Johns Hopkins School of Medicine.  The title of her doctoral dissertation is “Functional properties of the Kaposi’s Sarcoma associated Herpes Latency-Associated Nuclear Antigen (LANA).” She joined the Celgene Corporation as a postdoctoral associate in 2002 and has served since then in positions of increasing responsibility, achieving her present position in Dec. 2012. As Senior Principal Scientist she has translational medicine responsibilities in the corporation and in particular is responsible for developing strategies and biomarker assays supporting the progression of a Celgene anticancer compound (CC-122) in Phase I clinical trials.  Dr Gandhi also supervises a research group working on protein homeostasis, mechanisms of IMiD resistance, and the mechanism of action of IMiDs in oncology. She is an author of eighteen research articles and has made several presentations at various scientific meetings.

She will be covering the following topics:

  • Drug Development at Celgene
  • The IMiD Story
  • Careers in Translational Development

Jeffrey W. Thomas, PhD                                 

Frederick Unit Supervisor
Technology Transfer Center
National Cancer Institute

Dr. Thomas serves as a Unit Supervisor in the Technology Transfer Center at the National Cancer Institute.  In this position, Dr. Thomas and colleagues provide advice on intellectual property and technology transfer matters related to NCI intramural research collaborations, extramural grants and contracts, and various NCI programs.  Prior to joining the NCI Technology Transfer staff, Dr. Thomas received his Bachelor’s degree in Biology and Chemistry from Indiana University, and then joined Heritage Environmental Services in Indianapolis as a Staff Chemist.  He went on to establish a new environmental laboratory facility in Chicago and served as Chief Chemist.  Dr. Thomas then obtained his Ph.D. in Biochemistry from the University of Illinois at Urbana-Champaign studying structure-function relationships in bacterial oxidases.  After receiving his Ph.D., Dr. Thomas conducted postdoctoral research at the University of North Carolina at Chapel Hill studying protein tyrosine kinases.  He transitioned into the technology transfer field through the NCI Technology Transfer Fellowship Program.

Topics he will cover include:

  • What is Technology Transfer?
  • Who works in the Technology Transfer Arena?
  • Skills needed
  • NCI Technology Transfer Fellowship

Steven M. Ferguson, CLP

Director, Licensing and Entrepreneurship
Office of Technology Transfer
National Institutes of Health
sf8h@nih.gov

Steven M. Ferguson currently serves as a Deputy Director and senior licensing professional for the NIH Office of Technology Transfer, the patent & licensing office for technologies arising from the NIH, FDA & CDC intramural research programs. This technology portfolio includes about 1300 active licenses, 400 of which report product sales in aggregate greater than $6B per year.  

A former chemist at the National Cancer Institute, Mr. Ferguson holds Master's Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University).  

A registered Patent Agent and a Certified Licensing Professional (CLP), Mr. Ferguson is faculty and Technology Transfer Department Chair at the Foundation for Advanced Education in the Sciences (FAES) Graduate School at NIH as well as an Executive-in-Residence at the Johns Hopkins University Cary School of Business.

Mr. Ferguson is a project or business reviewer for many state and national funding organizations such as the India-U.S. Science & Technology Fund, Maryland Industrial Partnerships, and the Commonwealth Research Commercialization Fund and is faculty for the Biotechnology Industry Organization “Bio Boot Camp”.

He has received the AUTM President’s Award, the NIH Director’s Award, the FAES Instruction Award, the Federal Laboratory Consortium STEM Award, two “Deal of Distinction” awards from the Licensing Executive Society and fourteen NIH Merit Awards in recognition of his service and activities in the area of technology transfer.

Topics to be covered by Jeff include:

  • Careers In Technology Transfer & Business Development For Scientists
    • Yes, there is life after intramural research!
    • How can I consider technology transfer/business development as a career?
    • What are some of the daily activities in these jobs?
    • How do I best make the transition?
    • My own NCI career story …

Giovanni Melillo, MD

Senior Medical Director
Global Medicines Development
AstraZeneca Oncology
Gaithersburg, MD 20878

Dr. Giovanni Melillo obtained a Medical Doctor degree and a specialty in Medical Oncology from the University of Naples Medical School, Italy. He joined the Laboratory of Experimental Immunology of the National Cancer Institute in Frederick in 1991, where he discovered the presence of a hypoxia response element in the promoter of the inducible nitric oxide synthase gene. Between 1999 and 2011, Dr. Melillo held the position of Senior Investigator with the Developmental Therapeutics Program of the National Cancer Institute at Frederick where he contributed to the implementation of a translational program for the discovery and development of small molecule inhibitors of Hypoxia Inducible Factor 1 and was involved in the design and implementation of phase I clinical trials of molecularly targeted agents in cancer patients. From 2011 until 2013 Dr. Melillo was Medical Director, Exploratory Clinical and Translational Research at Bristol-Myers Squibb in Princeton, NJ, where he was involved in the early clinical development of novel therapeutic agents in Oncology. Dr. Melillo is currently Senior Medical Director, Global Medicines Development with AstraZeneca in Gaithersburg, MD. Dr. Melillo has served as Associate Editor of Cancer Research (2004-2012) and currently serves as AE of Journal of Molecular Medicine and is on the Editorial Board of Molecular Cancer Therapeutics, Cell Cycle, Molecular Cancer, and Cell Death and Disease.

Topics Dr. Melillo will cover include:

  • Challenges associated with developing a translational research program
  • Truth and myths about working in Industry: the Oncology paradigm
  • Transitioning from academia to Industry: challenges and opportunities.

Dr. Judy Britz, PhD

Executive Director
BioMaryland Center
jbritz@Bio.Maryland.gov
http://bio.maryland.gov/Pages/default.aspx

Dr. Judith Britz joined the BioMaryland Center as the Executive Director in January 2010.  Prior to joining the Center, Dr. Britz spent ten years in academia and 25 years in industry—including 15 years as an entrepreneur with two Maryland startup companies. She raised more than $50 million for these companies from strategic investors, venture capital, government and angel sources to bring products through the FDA process to market. Dr. Britz also held senior management positions at Becton Dickinson, Johnson and Johnson (Ortho Diagnostics Systems, Inc.) and Electro-Nucleonics, Inc. where she successfully developed one of the first commercial blood screening tests for the AIDS virus.

Dr. Britz’s academic credentials include a Ph.D. in Immunology and Microbiology from Stanford University and a Masters degree from MIT. She has held postdoctoral positions at Johns Hopkins and Yale Medical schools. Judy is a native of Maryland and graduated in Chemistry from Goucher College.

Please visit the Bio Maryland website for detail: http://bio.maryland.gov/Pages/default.aspx

Douglas Doerfler
President and CEO
MaxCyte, Inc.

Douglas Doerfler has over 30 years experience in the discovery, development and international financing and commercialization of biotechnology products and companies. He joined MaxCyte as its founding President and CEO in June 1999.

Prior to joining MaxCyte, he held senior corporate development and operating responsibilities for PFRM, Inc., a privately owned biotechnology holding company. He was President, Chief Executive Officer and a Director of Immunicon Corporation, a cell-based therapy and diagnostics company.

Doug also held various executive positions with Life Technologies that included leading global businesses, mergers and acquisitions and its IPO.

Doug plays an active role as an advocate for the life sciences industry and serves on the Biotechnology Industry Organization's Board of Directors and Co-Chairs BIO's Capital Formation Committee. He is Chairman of the Tech Council of Maryland and serves on the Executive Committee of the Alliance for Regenerative Medicine.

Doug received his B.S. in Finance from the University Of Baltimore School Of Business and holds a certificate in Industrial Relations. He will cover: startups, capital formation.

Anjan Thakurta, PhD

Senior Director, Translational Development
Multiple Myeloma
Celgene Corporation
Summit, NJ
athakurta@celgene.com

Anjan is currently a Senior Director of Translational Development at Celgene Corporation, a large biotech company based in New Jersey.  He leads the development and implementation of strategies for biomarker discovery and companion diagnostics development. His work involves developing R&D strategies for partnerships, outsourcing for the early development pipeline and managing integration efforts.  He has previously worked at AstraZeneca and Biogen Idec in various roles in oncology drug development and alliance management. He trained at Cambridge, Harvard and at the intramural NCI before moving to industry in 2006.

The topics of Anjan’s discussion will include:

  • Transitioning from academic research to industry: your SWOT analysis!
  • How do you prepare yourself? What I ask everyone in the interview
  • What can a PhD do in the industry? It’s not just lab work...
  • Experiences working at different companies—key lessons and takeaways
Home | Contact Us | Policies | Accessibility | Viewing Files | Search | CCR - For Our Staff

A service of the National Cancer Institute

National Cancer InstituteNational Institutes of HealthHealth and Human ServicesUSA Gov - Official Web Portal